Expression of RANK-L and in part of PD-1 on blasts in patients with acute myeloid leukemia correlates with prognosis (Q40790764)

23 September 2017

Expression of RANK-L and in part of PD-1 on blasts in patients with acute myeloid leukemia correlates with prognosis (English)

1 reference

23 September 2017

acute myeloid leukemia

1 reference

Joerg Uwe Schmohl

1

1 reference

23 September 2017

Tina Nuebling

2

1 reference

23 September 2017

Julia Wild

3

1 reference

23 September 2017

Tanja Kroell

4

1 reference

23 September 2017

Lothar Kanz

5

1 reference

23 September 2017

Helmut Rainer Salih

6

1 reference

23 September 2017

Helga Schmetzer

7

1 reference

23 September 2017

20 April 2016

1 reference

European Journal of Haematology

23 September 2017

1 reference

23 September 2017

97

1 reference

23 September 2017

6

1 reference

23 September 2017

517-527

1 reference

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

23 September 2017

1 reference

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

21 January 2018

1 reference

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

21 January 2018

1 reference

IL-23 promotes osteoclast formation by up-regulation of receptor activator of NF-kappaB (RANK) expression in myeloid precursor cells.

21 January 2018

1 reference

In vivo real-time imaging of TGF-beta-induced transcriptional activation of the RANK ligand gene promoter in intraosseous prostate cancer

21 January 2018

1 reference

RANKL expression specifically observed in vivo promotes epithelial mesenchymal transition and tumor progression

21 January 2018

1 reference

Oral squamous carcinoma cells secrete RANKL directly supporting osteolytic bone loss

21 January 2018

1 reference

Role of the RANKL/RANK system in the induction of interleukin-8 (IL-8) in B chronic lymphocytic leukemia (B-CLL) cells

21 January 2018

1 reference

Levels of soluble HLA-I and beta2M in patients with acute myeloid leukemia and advanced myelodysplastic syndrome: association with clinical behavior and outcome of induction therapy.

21 January 2018

1 reference

21 January 2018

The B7 family revisited

1 reference

The PD-1-PD-L pathway in immunological tolerance

21 January 2018

1 reference

Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity

21 January 2018

1 reference

Plasma cells from multiple myeloma patients express B7-H1 (PD-L1) and increase expression after stimulation with IFN-{gamma} and TLR ligands via a MyD88-, TRAF6-, and MEK-dependent pathway.

21 January 2018

1 reference

Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production

21 January 2018

1 reference

B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression

21 January 2018

1 reference

Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer

21 January 2018

1 reference

Expression of B7-H1 in breast cancer patients is strongly associated with high proliferative Ki-67-expressing tumor cells.

21 January 2018

1 reference

A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells

21 January 2018

1 reference

Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma

21 January 2018

1 reference

PD-1/PD-L1 interactions inhibit antitumor immune responses in a murine acute myeloid leukemia model

21 January 2018

1 reference

Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group

21 January 2018

1 reference

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

21 January 2018

1 reference

CD137 ligand mediates opposite effects in human and mouse NK cells and impairs NK-cell reactivity against human acute myeloid leukemia cells.

21 January 2018

1 reference

The erythroid leukemias: a comparative study of erythroleukemia (FAB M6) and Di Guglielmo disease

21 January 2018

1 reference

NF-kappaB in cancer: from innocent bystander to major culprit

21 January 2018

1 reference

Requirement of the NF-kappaB subunit p65/RelA for K-Ras-induced lung tumorigenesis

21 January 2018

1 reference

Myc suppression of Nfkb2 accelerates lymphomagenesis

21 January 2018

1 reference

B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease

21 January 2018

1 reference

A "vicious cycle" of NK-cell immune evasion in acute myeloid leukemia mediated by RANKL?

21 January 2018

1 reference

HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story

21 January 2018

1 reference

Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma expresses follicular T-cell markers.

21 January 2018

1 reference

Developmentally regulated expression of the PD-1 protein on the surface of double-negative (CD4-CD8-) thymocytes

21 January 2018

1 reference

The CD28 family: a T-cell rheostat for therapeutic control of T-cell activation.

21 January 2018

1 reference

Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer

21 January 2018

1 reference

Expression of programmed death-1 in primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoma, cutaneous pseudo-T-cell lymphoma, and other types of cutaneous T-cell lymphoma.

21 January 2018

1 reference

Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignancies

21 January 2018

1 reference

Anti-tumor immunotherapy by blockade of the PD-1/PD-L1 pathway with recombinant human PD-1-IgV.

21 January 2018

1 reference

Overexpression of PD-L1 significantly associates with tumor aggressiveness and postoperative recurrence in human hepatocellular carcinoma

21 January 2018

1 reference

In acute myeloid leukemia, B7-H1 (PD-L1) protection of blasts from cytotoxic T cells is induced by TLR ligands and interferon-gamma and can be reversed using MEK inhibitors.

21 January 2018

1 reference

Deletion of NEMO/IKKγ in Liver Parenchymal Cells Causes Steatohepatitis and Hepatocellular Carcinoma

21 January 2018

1 reference

https://api.fatcat.wiki/v0/release/jgo75qlj4jgvlelqatjlaqtbbe

21 January 2018

Identifiers

1 reference

mapped directly with Wikidata item

30 July 2022

based on heuristic

Fatcat ID

release_jgo75qlj4jgvlelqatjlaqtbbe

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jgo75qlj4jgvlelqatjlaqtbbe

mapped directly with Wikidata item

30 July 2022

based on heuristic

1 reference

https://api.fatcat.wiki/v0/release/jgo75qlj4jgvlelqatjlaqtbbe